Delivery Order SPE2DB22D2211-SPE2DB25FSDDU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 MG, valued at $1,604.37. This firm fixed-price delivery order, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Loperamide is an over-the-counter anti-diarrheal medication commonly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Loperamide 2 mg capsules (100 count) with a ceiling value of $1,067.84. This firm fixed-price delivery order represents a non-competitive award and is scheduled for completion by August 20, 2025, with performance occurring at the vendor's Conshohocken location. The award is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loperamide 2 mg capsules in unit dose packages of 100 units. This firm fixed-price delivery order, valued at $2,927.06, represents a non-competitive set-aside award and is scheduled for ultimate completion by July 22, 2025. The contract will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Loperamide 2 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $1,596.00, is scheduled for completion by August 11, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,088.65 to AmerisourceBergen Drug Corp for Loperamide 2 mg capsules in unit-dose packaging of 100 units. This competitively awarded, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 500 units of Loperamide 2mg tablets, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- This federal contract award, SPE2DX15D6028|SPE2DX25FWLNZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a delivery order for 4,568,164,160 units of the medication Loperamide 2 mg, with a ceiling value of $2,002.14. It is a firm-fixed-price contract with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred forty-eight dollars to Amerisourcebergen Drug Corporation for the supply of one hundred loperamide two milligram capsules. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 20, 2023 in support of the Agency's logistics and procurement programs. No subcontractors or set aside designations were indicated....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty thousand eight hundred fifty dollars to Amerisourcebergen Drug Corporation. The delivery order is for one hundred boxes of two milligram loperamide capsules to be shipped to a Conshohocken, Pennsylvania facility by August eighteenth, twenty twenty-three. Amerisourcebergen Drug Corporation will perform as the prime contractor for this order placed under an existing DLA contract vehicle. No set aside...
- This federal contract award, SPE2DB22D3301|SPE2DB25FY3XK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,501.99 firm fixed-price delivery order is for the supply of 4,568,053,642 units of the pharmaceutical product Loperamide 2 mg capsules. The contract has an ultimate completion date of April 29, 2025 and does not utilize any set-aside designation, indicating open competition....
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDDUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Loperamide 2 mg, valued at $1,074.23, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver pharmaceuticals and medical supplies globally to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, demonstrates substantial capability in fulfilling federal healthcare supply needs through both large-scale and small-value transactions. The company's extensive portfolio of federal contract awards encompasses a wide range of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Loperamide, an anti-diarrheal medication commonly used in military and veteran healthcare contexts, reflects the company's ongoing role as a trusted supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |